THE 5-SECOND TRICK FOR HEMGENIX

Range of eligible individuals: CDEC discussed the uncertainty in the number of individuals with reasonably intense to severe hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical gurus consulted by CADTH indicated that some people that are labeled as possessing gentle or moderate illness may have a severe bleeding phenotype, which